Nurulamin Noor
University of Cambridge
Nurulamin Noor is listed at University of Cambridge. Nurulamin is scheduled to speak at ECCO'27 – 22nd Congress of ECCO on 3 March 2027.
Compiled from published conference agendas; not yet confirmed by Nurulamin. Is this you? Claim this profile.
About
Nuru Noor is a Clinical Lecturer in Gastroenterology at the University of Cambridge and a Postdoctoral Researcher in Clinical Trial Methodology at the Medical Research Council Clinical Trials Unit. He has clinical and academic interests in IBD and clinical trials, with a focus on innovative approaches to trial design, conduct, analysis and reporting. He seeks to use novel approaches to clinical trial methodology to help deliver better outcomes for patients living with IBD.
Upcoming
ECCO'27 – 22nd Congress of ECCO 3 March 2027 – 6 March 2027
- 13th Y-ECCO Science Workshop - Session 1: Translational Research in IBD Speaker · 3 March 2027
- 13th Y-ECCO Science Workshop - Session 3: Cellular therapy in IBD Speaker · 3 March 2027
- 7th School for Clinical Trialists - Clinical Trials: innovation and beyond - Session 1: Clinical Trials: an evolving landscape Speaker · 3 March 2027
Spoke alongside
People who have shared a session with Nurulamin at events on B2DB.
- Ailsa Hart St. Mark's Hospital 1 shared session
- Andreia Sofia Barros Instituto de Investigação e Inovação em Saúde (I3S), University of Porto 1 shared session
- Edouard Louis CHU Liège, Sart Tilman 1 shared session
- Florian Tran 1 shared session
- Konstantinos Karmiris University Hospital 1 shared session
- Lauranne Derikx Erasmus MC 1 shared session
- Marieke Barnhoorn Postdoctoraal Onderzoeker IBD · Leiden University Medical Center 1 shared session
- Pearl Avery Wyke and Lanehouse Medical Centre 1 shared session
- Raja Atreya University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nürnberg 1 shared session